Comparison of three screening tools to detect psoriatic arthritis in patients with psoriasis (CONTEST study)
Open Access
- 11 January 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 168 (4) , 802-807
Abstract
Background Multiple questionnaires to screen for psoriatic arthritis (PsA) have been developed but the optimal screening questionnaire is unknown. Objectives To compare three PsA screening questionnaires in a head‐to‐head study using CASPAR (the Classification Criteria for Psoriatic Arthritis) as the gold standard. Methods This study recruited from 10 U.K. secondary care dermatology clinics. Patients with a diagnosis of psoriasis, not previously diagnosed with PsA, were given all three questionnaires. All patients who were positive on any questionnaire were invited for a rheumatological assessment. Receiver operating characteristic (ROC) curves were used to compare the sensitivity, specificity and area under the curve of the three questionnaires according to CASPAR criteria. Results In total, 938 patients with psoriasis were invited to participate and 657 (70%) patients returned the questionnaires. One or more questionnaires were positive in 314 patients (48%) and 195 (62%) of these patients attended for assessment. Of these, 47 patients (24%) were diagnosed with PsA according to the CASPAR criteria. The proportion of patients with PsA increased with the number of positive questionnaires (one questionnaire, 19·1%; two, 34·0%; three, 46·8%). Sensitivities and specificities for the three questionnaires, and areas under the ROC curve were, respectively: Psoriatic Arthritis Screening Evaluation (PASE), 74·5%, 38·5%, 0·594; Psoriasis Epidemiology Screening Tool (PEST), 76·6%, 37·2%, 0·610; Toronto Psoriatic Arthritis Screen (ToPAS), 76·6%, 29·7%, 0·554. The majority of patients with a false positive response had degenerative or osteoarthritis. Conclusion Although the PEST and ToPAS questionnaires performed slightly better than the PASE questionnaire at identifying PsA, there is little difference between these instruments. These screening tools identify many cases of musculoskeletal disease other than PsA.Keywords
This publication has 14 references indexed in Scilit:
- Diagnosis and management of psoriasis and psoriatic arthritis in adults: summary of SIGN guidanceBMJ, 2010
- The prevalence of psoriatic arthritis in people with psoriasisArthritis Care & Research, 2009
- Development and initial validation of a screening questionnaire for psoriatic arthritis: the Toronto Psoriatic Arthritis Screen (ToPAS)Annals of the Rheumatic Diseases, 2009
- Lower limb enthesopathy in patients with psoriasis without clinical signs of arthropathy: a hospital-based case–control studyAnnals of the Rheumatic Diseases, 2008
- The PASE questionnaire: Pilot-testing a Psoriatic Arthritis Screening and Evaluation toolJournal of the American Academy of Dermatology, 2007
- Classification criteria for psoriatic arthritis: Development of new criteria from a large international studyArthritis & Rheumatism, 2006
- Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritisAnnals of the Rheumatic Diseases, 2004
- Strategies for improving power in diagnostic radiology research.American Journal of Roentgenology, 1992
- STANFORD HEALTH ASSESSMENT QUESTIONNAIRE MODIFIED TO ASSESS DISABILITY IN BRITISH PATIENTS WITH RHEUMATOID ARTHRITISRheumatology, 1986
- Severe Psoriasis – Oral Therapy with a New RetinoidDermatology, 1978